Nutex Cost Of Revenue vs Reconciled Depreciation Analysis

NUTX Stock

USD 34.76 0.54 1.58%

Nutex Health financial indicator trend analysis is infinitely more than just investigating Nutex Health recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nutex Health is a good investment. Please check the relationship between Nutex Health Cost Of Revenue and its Reconciled Depreciation accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nutex Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Nutex Stock please use our How to Invest in Nutex Health guide.

Cost Of Revenue vs Reconciled Depreciation

Cost Of Revenue vs Reconciled Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nutex Health Cost Of Revenue account and Reconciled Depreciation. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Nutex Health's Cost Of Revenue and Reconciled Depreciation is 0.93. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Reconciled Depreciation in the same time period over historical financial statements of Nutex Health, assuming nothing else is changed. The correlation between historical values of Nutex Health's Cost Of Revenue and Reconciled Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of Nutex Health are associated (or correlated) with its Reconciled Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Reconciled Depreciation has no effect on the direction of Cost Of Revenue i.e., Nutex Health's Cost Of Revenue and Reconciled Depreciation go up and down completely randomly.

Correlation Coefficient

0.93

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Nutex Health income statement and represents the costs associated with goods and services Nutex Health provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Reconciled Depreciation

Most indicators from Nutex Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nutex Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nutex Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Nutex Stock please use our How to Invest in Nutex Health guide.Enterprise Value is likely to rise to about 8.3 B in 2024, whereas Selling General Administrative is likely to drop slightly above 26.3 M in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	5.5M	18.0M	66.5M	69.9M
Cost Of Revenue	152.3M	205.8M	212.9M	223.5M

Total Operating Expenses Cost Of Revenue

Nutex Health fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Good Will	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Non Current Liabilities Total	Current Deferred Revenue	Non Currrent Assets Other	Common Stock	Short Long Term Debt Total	Short Term Debt	Intangible Assets	Inventory
Common Stock Shares Outstanding		0.21	-0.27	0.18	0.37	0.2	0.12	0.12	0.07	0.35	0.18	0.35	0.36	-0.08	-0.67	-0.04	0.12	0.34	0.19	-0.63	0.4	0.0	0.15	0.33	-0.15	0.2
Total Assets	0.21		0.71	0.86	0.9	1.0	0.97	-0.67	0.95	0.91	0.99	0.91	0.86	0.76	-0.29	0.8	0.98	0.88	0.95	-0.51	0.67	0.86	0.98	0.55	0.67	0.97
Other Current Liab	-0.27	0.71		0.84	0.43	0.74	0.8	-0.71	0.74	0.47	0.76	0.47	0.4	0.76	0.17	0.74	0.79	0.43	0.67	-0.26	0.42	0.72	0.78	0.57	0.71	0.68
Total Current Liabilities	0.18	0.86	0.84		0.68	0.89	0.9	-0.64	0.77	0.69	0.88	0.69	0.65	0.69	-0.23	0.73	0.89	0.67	0.79	-0.48	0.78	0.68	0.89	0.86	0.61	0.81
Total Stockholder Equity	0.37	0.9	0.43	0.68		0.87	0.77	-0.35	0.77	0.99	0.84	0.99	0.96	0.47	-0.34	0.52	0.79	0.98	0.87	-0.46	0.67	0.69	0.8	0.45	0.36	0.9
Property Plant And Equipment Net	0.2	1.0	0.74	0.89	0.87		0.98	-0.72	0.96	0.89	1.0	0.89	0.81	0.8	-0.29	0.84	0.99	0.84	0.95	-0.51	0.65	0.88	0.99	0.58	0.72	0.97
Net Debt	0.12	0.97	0.8	0.9	0.77	0.98		-0.82	0.96	0.79	0.99	0.79	0.71	0.88	-0.24	0.91	1.0	0.74	0.93	-0.5	0.62	0.88	1.0	0.58	0.81	0.94
Retained Earnings	0.12	-0.67	-0.71	-0.64	-0.35	-0.72	-0.82		-0.82	-0.41	-0.76	-0.41	-0.24	-0.98	0.02	-0.98	-0.81	-0.28	-0.73	0.3	-0.21	-0.76	-0.79	-0.28	-0.99	-0.7
Accounts Payable	0.07	0.95	0.74	0.77	0.77	0.96	0.96	-0.82		0.8	0.97	0.8	0.68	0.9	-0.2	0.91	0.97	0.72	0.93	-0.44	0.42	0.96	0.97	0.36	0.84	0.95
Cash	0.35	0.91	0.47	0.69	0.99	0.89	0.79	-0.41	0.8		0.87	1.0	0.93	0.53	-0.34	0.57	0.82	0.96	0.91	-0.48	0.63	0.73	0.83	0.44	0.43	0.93
Non Current Assets Total	0.18	0.99	0.76	0.88	0.84	1.0	0.99	-0.76	0.97	0.87		0.87	0.78	0.84	-0.27	0.87	1.0	0.81	0.95	-0.5	0.62	0.9	1.0	0.56	0.76	0.97
Cash And Short Term Investments	0.35	0.91	0.47	0.69	0.99	0.89	0.79	-0.41	0.8	1.0	0.87		0.93	0.53	-0.34	0.57	0.82	0.96	0.91	-0.48	0.63	0.73	0.83	0.44	0.43	0.93
Net Receivables	0.36	0.86	0.4	0.65	0.96	0.81	0.71	-0.24	0.68	0.93	0.78	0.93		0.34	-0.38	0.41	0.73	0.99	0.79	-0.5	0.77	0.57	0.75	0.49	0.22	0.82
Good Will	-0.08	0.76	0.76	0.69	0.47	0.8	0.88	-0.98	0.9	0.53	0.84	0.53	0.34		-0.03	0.99	0.87	0.39	0.8	-0.33	0.23	0.86	0.86	0.29	0.99	0.79
Other Current Assets	-0.67	-0.29	0.17	-0.23	-0.34	-0.29	-0.24	0.02	-0.2	-0.34	-0.27	-0.34	-0.38	-0.03		-0.09	-0.23	-0.33	-0.25	0.73	-0.39	-0.15	-0.26	-0.31	0.01	-0.27
Other Stockholder Equity	-0.04	0.8	0.74	0.73	0.52	0.84	0.91	-0.98	0.91	0.57	0.87	0.57	0.41	0.99	-0.09		0.9	0.46	0.83	-0.37	0.34	0.85	0.89	0.35	0.97	0.81
Total Liab	0.12	0.98	0.79	0.89	0.79	0.99	1.0	-0.81	0.97	0.82	1.0	0.82	0.73	0.87	-0.23	0.9		0.76	0.94	-0.49	0.6	0.9	1.0	0.55	0.8	0.96
Total Current Assets	0.34	0.88	0.43	0.67	0.98	0.84	0.74	-0.28	0.72	0.96	0.81	0.96	0.99	0.39	-0.33	0.46	0.76		0.83	-0.47	0.73	0.62	0.77	0.47	0.28	0.86
Non Current Liabilities Total	0.19	0.95	0.67	0.79	0.87	0.95	0.93	-0.73	0.93	0.91	0.95	0.91	0.79	0.8	-0.25	0.83	0.94	0.83		-0.47	0.56	0.86	0.94	0.47	0.73	0.99
Current Deferred Revenue	-0.63	-0.51	-0.26	-0.48	-0.46	-0.51	-0.5	0.3	-0.44	-0.48	-0.5	-0.48	-0.5	-0.33	0.73	-0.37	-0.49	-0.47	-0.47		-0.51	-0.37	-0.5	-0.42	-0.25	-0.48
Non Currrent Assets Other	0.4	0.67	0.42	0.78	0.67	0.65	0.62	-0.21	0.42	0.63	0.62	0.63	0.77	0.23	-0.39	0.34	0.6	0.73	0.56	-0.51		0.23	0.63	0.86	0.12	0.57
Common Stock	0.0	0.86	0.72	0.68	0.69	0.88	0.88	-0.76	0.96	0.73	0.9	0.73	0.57	0.86	-0.15	0.85	0.9	0.62	0.86	-0.37	0.23		0.88	0.24	0.83	0.89
Short Long Term Debt Total	0.15	0.98	0.78	0.89	0.8	0.99	1.0	-0.79	0.97	0.83	1.0	0.83	0.75	0.86	-0.26	0.89	1.0	0.77	0.94	-0.5	0.63	0.88		0.57	0.78	0.96
Short Term Debt	0.33	0.55	0.57	0.86	0.45	0.58	0.58	-0.28	0.36	0.44	0.56	0.44	0.49	0.29	-0.31	0.35	0.55	0.47	0.47	-0.42	0.86	0.24	0.57		0.21	0.48
Intangible Assets	-0.15	0.67	0.71	0.61	0.36	0.72	0.81	-0.99	0.84	0.43	0.76	0.43	0.22	0.99	0.01	0.97	0.8	0.28	0.73	-0.25	0.12	0.83	0.78	0.21		0.71
Inventory	0.2	0.97	0.68	0.81	0.9	0.97	0.94	-0.7	0.95	0.93	0.97	0.93	0.82	0.79	-0.27	0.81	0.96	0.86	0.99	-0.48	0.57	0.89	0.96	0.48	0.71

Click cells to compare fundamentals

Nutex Health Account Relationship Matchups

Nutex Health fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	41.4M	42.9M	39.5M	42.3M	4.4M	4.2M
Total Assets	179.2M	308.6M	394.7M	431.8M	398.2M	418.2M
Other Current Liab	9.9M	2.4M	6.9M	8.8M	13.0M	13.6M
Total Current Liabilities	72.1M	31.5M	37.7M	54.9M	58.3M	61.2M
Total Stockholder Equity	28.3M	85.8M	114.7M	95.9M	61.5M	38.6M
Property Plant And Equipment Net	131.3M	170.8M	238.4M	295.2M	269.4M	282.9M
Net Debt	111.9M	124.6M	142.4M	232.9M	253.8M	266.4M
Retained Earnings	(12.6M)	(18.2M)	102.3M	(363.3M)	(409.1M)	(388.6M)
Accounts Payable	1.8M	8.6M	17.7M	23.9M	25.3M	26.5M
Cash	8.0M	25.5M	36.1M	34.3M	22.0M	12.7M
Non Current Assets Total	133.5M	173.0M	240.6M	333.8M	307.4M	322.8M
Cash And Short Term Investments	8.0M	25.5M	36.1M	34.3M	22.0M	12.7M
Net Receivables	36.1M	108.1M	114.8M	58.3M	62.8M	41.9M
Liabilities And Stockholders Equity	179.2M	308.6M	394.7M	431.8M	398.2M	418.2M
Other Current Assets	700.1K	130.6K	323.3K	1.9M	2.7M	2.8M
Other Stockholder Equity	40.9M	104.0M	11.7M	458.5M	469.8M	493.3M
Total Liab	128.4M	161.2M	203.1M	311.4M	319.1M	335.1M
Total Current Assets	45.7M	135.5M	154.0M	98.0M	90.8M	53.7M
Non Current Liabilities Total	56.3M	129.7M	165.4M	256.6M	260.8M	136.7M
Current Deferred Revenue	9.2K	165.6K	38.7K	173.9K	156.5K	161.0K
Non Currrent Assets Other	1.1M	1.1M	456.1K	423.4K	431.1K	427.4K
Common Stock	4.6K	5.3K	592.8K	650.2K	676.7K	710.5K
Short Long Term Debt Total	119.9M	150.1M	178.6M	267.2M	275.8M	289.5M
Short Term Debt	63.7M	20.4M	13.2M	21.1M	20.1M	19.2M
Intangible Assets	2.6M	1.5M	682.6K	21.2M	20.5M	21.5M
Inventory	899.9K	1.7M	2.8M	3.5M	3.4M	2.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for Nutex Stock Analysis

When running Nutex Health's price analysis, check to measure Nutex Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutex Health is operating at the current time. Most of Nutex Health's value examination focuses on studying past and present price action to predict the probability of Nutex Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutex Health's price. Additionally, you may evaluate how the addition of Nutex Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Nutex Cost Of Revenue vs Reconciled Depreciation Analysis

Cost Of Revenue vs Reconciled Depreciation

Cost Of Revenue vs Reconciled Depreciation Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Reconciled Depreciation

Nutex Health fundamental ratios Correlations

Nutex Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Nutex Health fundamental ratios Accounts

Also Currently Popular

Additional Tools for Nutex Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Net	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Total Liab	+ 1.0	Net Debt
Short Long Term Debt Total	+ 1.0	Net Debt
Cash And Short Term Investments	+ 1.0	Cash
Total Liab	+ 1.0	Non Current Assets Total

Intangible Assets	- 0.99	Retained Earnings
Other Stockholder Equity	- 0.98	Retained Earnings
Good Will	- 0.98	Retained Earnings
Accounts Payable	- 0.82	Retained Earnings
Retained Earnings	- 0.82	Net Debt
Total Liab	- 0.81	Retained Earnings